Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
We discuss early results from an ongoing study of a triple combination therapy with a PD-L1 checkpoint inhibitor for treating Richter’s transformation.
Margaret wrote this heart-wrenchingly honest and lucid account of her young husband’s passing soon after his chronic lymphocytic leukemia (CLL) went bad and transformed to Richter’s Syndrome or Transformation. Not everyone who develops Richter’s has such a grim story, but sadly too many still do.
Treatments for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL / SLL) are being developed to address refractory cases, in other words, those that no longer respond to current therapies. In this study presented at the American Society of Hematology Annual Meeting and Exhibition (ASH 2021), the results of early (phase 1a/b) trials on Luxeptinib in 23 patients are reviewed.
CLL Society Medical Advisory Board CLL Society’s Medical Advisory Board is comprised of leading CLL / SLL experts from across the country. Members generously provide their time and talent to the
CLL Clinical Trials CLL is not a solved problem, but we do have excellent treatments. It was only through clinical trials that the safety and efficacy of existing therapies was proven, and the
Abbreviations & Acronyms In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical
Recorded Saturday, October 10, 2020 Flash Session 1: Richter’s Transformation https://youtu.be/LbrVcvY9Lw4 CLL Society Resources Download Slides Audience Questions Agenda About CLL Society Sign up for CLL Society’s This Week emails
Recorded Saturday, October 10, 2020 Welcome and Introductions SPEAKERPatricia KoffmanCo-Founder and Communications DirectorCLL Society Click to play Session 1: Definitions, Diagnosis, Test Before Treat™ and Early Management in CLL MODERATORBrian Koffman,
When I was first diagnosed in April 2018, my WBC was at 55k, my local Hematologist performed the FISH test and found out I had 11Q with loss of ATM, they
One click to our most popular content.
